Cleveland Clinic Rheumatology
Avatar

Inflammatory Arthritis and Sicca Syndrome Induced by Nivolumab and Ipilimumab

By Cleveland Clinic Rheumatology FEATURING Leonard Calabrese, Laura Cappelli, Cassandra Calabrese
By Cleveland Clinic Rheumatology FEATURING Leonard Calabrese, Laura Cappelli, Cassandra Calabrese
532 views
January 15, 2019
0 Comments
Login to view comments. Click here to Login

Featured Video

27:06
Lilly Dermatology

Overview of Efficacy and Safety Data for a Biologic Therapy in Plaqu…

Feat. J. Peterson, J. Song

Featured Video

16:27
Lilly Dermatology

Moderate-to-Severe Plaque Psoriasis: Patient Case Study and Clinical…

Feat. M. Jackson

Related Content

AUTOPLAY
21:20
Cleveland Clinic Rheumatology

How do I Recognize and Treat the VEXAS Syndrome?

Feat. P. Grayson
18:47
Total Health

Updates in the Management of NSCLC: Systemic Therapy Year in Review

Feat. W. Iams
35:40
Balazs Halmos

Year in Review: Lung Cancer

17:20
Total Health

2024 Intervention Selection & Sequencing in Early Stage NSCLC

Feat. J. Porter
13:19
IASLC Targeted Therapies of Lung Cancer 2023 Conference Coverage

Duration of Immunotherapy Beyond 2 Years for Patients With Advanced …

Feat. E. Rodriguez
08:49
David Carbone

The Use of IO Doublet in PD-L1-Negative NSCLC

09:40
John Conibear

PACIFIC Trial 5-Year OS Data: Clinical Implications in NSCLC

45:56
Yale Cancer Center

Endocrine Adverse Events From Checkpoint Inhibitors

Feat. K. Herold
07:31
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "KEYNOTE-671 Trial Key Learnings & Cli…

Feat. J. West
14:49
Vivek Subbiah

Year in Review: Precision Medicine

28:21
Houston Methodist Hospital

Palliative Medicine in Cancer Patients

Feat. E. De Leon
16:12
Total Health

2024 Updates on the Fast-Changing NSCLC Landscape

Feat. R. Osarogiagbon
23:32
2023 West Oncology Conference

2023 Updates on Neoadjuvant and Adjuvant NSCLC

Feat. M. Johnson
11:50
GRACE

The CheckMate 816 Trial: The Success of Neoadjuvant NSCLC Therapies

Feat. J. Rotow
17:34
ecancer

Recent NSCLC Updates Including PAPILLON, CHECKMATE 77T, and KEYNOTE-…

Feat. L. Raez
20:27
Yale Cancer Center

Progress in the Treatment of NSCLC

Feat. R. Herbst
54:26
Yale Cancer Center

Year in Review: Progress in NSCLC Treatment

Feat. R. Herbst
23:36
CHEST 2022 Coverage

Immune Checkpoint Inhibitor Pneumonitis in Lung Cancer

Feat. J. Possick
26:42
Total Health

ADAURA & KEYNOTE-671 Trials: Early Stage NSCLC Updates - 2023 AS…

Feat. J. Bauman
17:57
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Summary: "Expert Discussion on New Treatment Options…

Feat. D. Carbone, B. Stiles